Press | FuturHealth

More from the Newsroom

Press Release FuturHealth Releases New Efficacy Data Data shows enhanced weight loss outcomes with GLP-1 treatments February 25, 2025

Take precaution with, and read all warnings concerning, GLP-1s, as they may cause serious side effects, including a risk of thyroid c-cell tumors. Do not use if you or your family have a history of a type of thyroid cancer called MTC (medullary thyroid carcinoma) or MEN 2 (multiple endocrine neoplasia syndrome). *Images of the FH application are representative of the types of features and services offered and may not exactly match what is shown in the application. *Individual results may vary based on starting weight and program adherence including but not limited to diet and exercise. Average % body weight reduction as analyzed by InCSD in “A Retrospective Study to Evaluate the Effectiveness of FuturHealth Program Alone or in Combination with GLP-1 Treatment in Weight Management in Participants ≥ 18 Years Old.” Contact us